Status:
COMPLETED
Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
Lead Sponsor:
Federico II University
Conditions:
Obesity
Eligibility:
FEMALE
45-65 years
Brief Summary
The beneficial effects on plasma lipids of Orlistat, a selective gastrointestinal lipase inhibitor, are largely independent of weight loss, and might include differential effects plasma non-esterified...
Detailed Description
Subjects: Twenty obese postmenopausal women (age: 53.6±6.2; BMI: 34.1±4.0. Subjects were recruited, evaluated, and monitored at the Endocrinology Unit of the Department of Molecular and Clinical Endo...
Eligibility Criteria
Inclusion
- women
- post-menopausal age
- class I-II obesity
- normal thyroid, liver, and kidney function
Exclusion
- type 2 diabetes mellitus
- use of hypolipaemic agents
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00991926
Start Date
December 1 2006
End Date
February 1 2009
Last Update
October 14 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.